Concluding remarks and outlook for the use of 5-HT3 receptor antagonists in rheumatology.
Pongratz
D
D
Friedrich Baur Institute, Munich, Germany.
Stratz
T
T
Müller
W
W
D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy*; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists